MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6.

导出 OA

翻译打印收藏纠错

第一作者： Kegan,Zhu

第一单位： Department of Orthopedics, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, 210002, China.

作者： Kegan,Zhu ^[1] ; Lei,Liu ^[2] ; Junliang,Zhang ^[3] ; Yanbo,Wang ^[1] ; Hongwei,Liang ^[2] ; Gentao,Fan ^[2] ; Zhenhuan,Jiang ^[1] ; Chen-Yu,Zhang ^[3] ; Xi,Chen ^[4] ; Guangxin,Zhou ^[5]

作者单位： Department of Orthopedics, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, 210002, China. ^[1] State Key Laboratory of Pharmaceutical Biotechnology, Collaborative Innovation Center of Chemistry for Life Sciences, NJU Advanced Institute for Life Sciences (NAILS), Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210046, China. ^[2] Department of Orthopedics, The Affiliated Yixing Hospital of Jiangsu University, Yixing, 214200, China. ^[3] State Key Laboratory of Pharmaceutical Biotechnology, Collaborative Innovation Center of Chemistry for Life Sciences, NJU Advanced Institute for Life Sciences (NAILS), Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210046, China. cyzhang@nju.edu.cn. ^[4] State Key Laboratory of Pharmaceutical Biotechnology, Collaborative Innovation Center of Chemistry for Life Sciences, NJU Advanced Institute for Life Sciences (NAILS), Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210046, China. xichen@nju.edu.cn. ^[5] Department of Orthopedics, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, 210002, China. oxis@163.com. ^[6]

关键词 miR-29b migration osteosarcoma proliferation tumorigenesis